Luyan Pharma Co Ltd (002788) — Cash Flow-to-Debt Ratio
Luyan Pharma Co Ltd (002788) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of CN¥118.98 Million could theoretically repay 0% of its total liabilities (CN¥9.78 Billion) in one year. See financial flexibility index of Luyan Pharma Co Ltd to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Luyan Pharma Co Ltd Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Luyan Pharma Co Ltd across 15 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Luyan Pharma Co Ltd.
Annual Cash Flow-to-Debt Ratio for Luyan Pharma Co Ltd (2011–2025)
Year-by-year debt coverage analysis for Luyan Pharma Co Ltd. Check how high is Luyan Pharma Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.07x | CN¥688.40 Million | CN¥10.07 Billion | ▲ +11.8% |
| 2024 | 0.06x | CN¥577.48 Million | CN¥9.45 Billion | ▼ -58.8% |
| 2023 | 0.15x | CN¥1.31 Billion | CN¥8.82 Billion | ▲ +475.1% |
| 2022 | 0.03x | CN¥232.19 Million | CN¥8.99 Billion | ▲ +151.6% |
| 2021 | -0.05x | CN¥-372.02 Million | CN¥7.43 Billion | ▼ -490.8% |
| 2020 | 0.01x | CN¥77.22 Million | CN¥6.03 Billion | ▲ +111.5% |
| 2019 | -0.11x | CN¥-629.14 Million | CN¥5.65 Billion | ▼ -488.0% |
| 2018 | 0.03x | CN¥126.77 Million | CN¥4.42 Billion | ▲ +122.9% |
| 2017 | -0.13x | CN¥-447.16 Million | CN¥3.57 Billion | ▼ -108.9% |
| 2016 | -0.06x | CN¥-128.03 Million | CN¥2.13 Billion | ▼ -73521.7% |
| 2015 | 0.00x | CN¥219.31K | CN¥2.68 Billion | ▼ -99.9% |
| 2014 | 0.07x | CN¥177.89 Million | CN¥2.66 Billion | ▲ +298.0% |
| 2013 | -0.03x | CN¥-76.47 Million | CN¥2.27 Billion | ▼ -81.8% |
| 2012 | -0.02x | CN¥-32.94 Million | CN¥1.78 Billion | ▼ -164.4% |
| 2011 | 0.03x | CN¥28.01 Million | CN¥973.17 Million | — |